Mictonorm Uno

Propiverine Hydrochloride, the active ingredient in Mictonorm Uno, is an antimuscarinic (anticholinergic) presented as an oral tablet for oral use. It is indicated for the management of overactive bladder symptoms such as urgency, frequency, and urge incontinence in adult patients.

GNH USA supplies Mictonorm Uno as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mictonorm Uno belongs to the antimuscarinic class and acts on the lower urinary tract to improve bladder storage function.

Overactive bladder: reduces urgency episodes and increases functional bladder capacity. Urinary urgency: diminishes the sudden need to void. Urinary frequency: lowers the number of daily voids. Urge urinary incontinence: decreases involuntary leakage episodes.

Common Side Effects: - Dry mouth - Constipation - Blurred vision - Headache - Dizziness - Nausea

Serious or Rare Side Effects: - Urinary retention - Severe allergic reaction (anaphylaxis) - Tachycardia or palpitations - Acute angle‑closure glaucoma - Hepatic enzyme elevation - Persistent severe constipation

Precautions should be taken to ensure safe use of Mictonorm Uno.

Assess renal function: adjust use in patients with impaired renal clearance. Avoid in patients with urinary retention: risk of worsening blockage. Use caution in the elderly: increased sensitivity to anticholinergic effects. Review concomitant anticholinergic load: limit additive side‑effects. Monitor for glaucoma: anticholinergic activity may precipitate angle‑closure. Store at room temperature: keep in the original pack, protect from moisture.

Potential drug interactions may affect the safety or efficacy of Mictonorm Uno.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole) - Other potent anticholinergics (e.g., trihexyphenidyl) - Drugs that prolong QT interval (e.g., certain antiarrhythmics)

Moderate Interactions (Monitor Closely):\n- CYP3A4 inducers (e.g., rifampin, carbamazepine) - Diuretics (may increase risk of urinary retention) - Antihistamines with anticholinergic properties (e.g., diphenhydramine)